The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Robitussin Plus Oral Solution Guaifenesin 100 mg/5ml Pseudoephedrine HCl 30 mg/5ml



GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/154/001

Main Information

Trade NameRobitussin Plus Oral Solution Guaifenesin 100 mg/5ml Pseudoephedrine HCl 30 mg/5ml
Active SubstancesGuaiphenesin
PSEUDOEPHEDRINE HYDROCHLORIDE
Dosage FormOral solution
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/154/001

Group Information

ATC CodeR01BA Sympathomimetics
R01BA52 pseudoephedrine, combinations

Status

License statusAuthorised
Licence Issued29/07/1985
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back